Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors

开发一种新颖的非激素治疗模式来治疗乳腺癌幸存者的阴道干燥

基本信息

  • 批准号:
    10247092
  • 负责人:
  • 金额:
    $ 84.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-01 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

Abstract The goal of this Fast-Track SBIR is to demonstrate the safety and efficacy of a therapeutic-ultrasound-based medical device to treat the symptoms of vaginal dryness for breast cancer survivors and postmenopausal women. Today's best treatments for vaginal dryness all involve the use of hormones; yet, hormonal treatments are contraindicated for the 1.4 million breast cancer survivors suffering from vaginal dryness (due to the risk of cancer recurrence). Further, millions of postmenopausal women avoid hormone use because of the long-term risks and unpleasant side effects. Madorra has developed a medical device that uses therapeutic ultrasound to revitalize vaginal lubrication, abating symptoms of vaginal dryness completely without the need for hormone therapy. Preliminary research conducted by the Madorra team has indicated the promise of vaginally applied therapeutic ultrasound to treat vaginal dryness when used daily in the home by women suffering from vaginal dryness. However, the modified off-the-shelf ultrasound devices used in those studies were cumbersome and posed significant usability challenges for the study participants. Women in the study complained about the user interface, challenges in programming the correct ultrasound dose, difficulty positioning and holding the device during therapy, and the burdens of cleaning the device after each use. Accordingly, an ultrasound device that can effectively deliver desired ultrasound directly to vaginal tissue while being easily used (and hence readily adopted by end users) is required. Madorra has developed such a device based on this user feedback, but it has not yet been tested clinically. This Fast-Track SBIR proposal would support the first clinical use of the Madorra device. Phase I encompasses a small, single-arm, Pilot Study of the Madorra device, and Phase II comprises a larger randomized, sham-controlled Pivotal Study. The Pilot Study (Specific Aims 1-3) will be used to gather initial clinical use experience data on the Madorra device, including: safety, proof of physiologic response, validation for ease of use, and preliminary efficacy. The Pivotal Study (Specific Aims 4-6) will collect statistically significant safety and efficacy data demonstrating the Madorra device's ability to treat vaginal dryness in comparison to a sham device. These data will be submitted to the FDA in support of device approval and will serve to irrevocably establish the clinical efficacy of the Madorra device. Once FDA approved, the Madorra device will be commercialized and will allow millions of breast cancer survivors and postmenopausal women to regain their sexual wellness and improve their quality of life.   1
抽象的 该快速通道 SBIR 的目标是证明基于超声治疗的安全性和有效性 用于治疗乳腺癌幸存者和绝经后阴道干燥症状的医疗设备 女性。当今治疗阴道干燥的最佳方法都涉及使用激素。然而,荷尔蒙治疗 对于 140 万患有阴道干燥的乳腺癌幸存者来说是禁忌的(因为存在以下风险) 癌症复发)。此外,数以百万计的绝经后妇女避免使用激素,因为长期 风险和令人不快的副作用。 Madorra 开发了一种医疗设备,利用治疗超声波来治疗 恢复阴道润滑,完全减轻阴道干燥症状,无需激素 治疗。 Madorra 团队进行的初步研究表明了阴道应​​用的前景 患有阴道疾病的女性每天在家中使用治疗性超声波治疗阴道干燥 干燥。然而,这些研究中使用的经过改进的现成超声设备非常笨重并且 给研究参与者带来了重大的可用性挑战。研究中的女性抱怨用户 界面、对正确超声剂量进行编程的挑战、定位和握住设备的困难 治疗期间的负担,以及每次使用后清洁设备的负担。因此,超声装置 可以有效地将所需的超声波直接传递到阴道组织,同时易于使用(因此很容易 最终用户采用)是必需的。 Madorra 根据用户反馈开发了这样的设备,但它 尚未经过临床测试。该快速通道 SBIR 提案将支持该药物的首次临床使用 马多拉装置。第一阶段包括对 Madorra 装置的小型单臂试点研究,第二阶段包括 包括一项更大的随机、假对照关键研究。将使用试点研究(具体目标 1-3) 收集 Madorra 设备的初步临床使用经验数据,包括:安全性、生理学证明 响应、易用性验证和初步功效。关键研究(具体目标 4-6)将收集 统计上显着的安全性和有效性数据证明了 Madorra 装置治疗阴道疾病的能力 与假设备相比的干燥度。这些数据将提交给 FDA 以支持设备 批准并将不可撤销地确定 Madorra 装置的临床疗效。曾经FDA 获得批准后,Madorra 设备将商业化,并使数百万乳腺癌幸存者和 绝经后妇女恢复性健康并提高生活质量。   1

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Holly Rockweiler其他文献

Holly Rockweiler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Holly Rockweiler', 18)}}的其他基金

Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors
开发一种新颖的非激素治疗模式来治疗乳腺癌幸存者的阴道干燥
  • 批准号:
    9557201
  • 财政年份:
    2018
  • 资助金额:
    $ 84.85万
  • 项目类别:
Developing a novel, non-hormonal treatment paradigm for vaginal dryness in breast cancer survivors
开发一种新颖的非激素治疗模式来治疗乳腺癌幸存者的阴道干燥
  • 批准号:
    10228246
  • 财政年份:
    2018
  • 资助金额:
    $ 84.85万
  • 项目类别:

相似海外基金

StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
  • 批准号:
    10577022
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
A Controlled Study of Extended Cannabis Abstinence in Major Depression
重度抑郁症患者长期吸食大麻的对照研究
  • 批准号:
    478313
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
    Operating Grants
Exercised-induced modulation of insular cortex microcircuitry during alcohol abstinence
戒酒期间运动诱导的岛叶皮质微电路调节
  • 批准号:
    10748763
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
Prapela™ SVS:一种经济高效的随机振动触觉刺激装置,可改善患有新生儿戒断综合征的婴儿的临床过程。
  • 批准号:
    10837421
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Enforced alcohol abstinence: does it reduce reoffending?
强制戒酒:会减少再犯罪吗?
  • 批准号:
    ES/X003566/1
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
    Fellowship
Neurobiological impact of acute digital media abstinence among drug using college students
吸毒大学生急性数字媒体戒断的神经生物学影响
  • 批准号:
    10677380
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Single-cell whole brain imaging of nicotine intoxication, dependence, and abstinence
尼古丁中毒、依赖和戒断的单细胞全脑成像
  • 批准号:
    10588509
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Understanding recovery from alcohol use disorder: Longitudinal observation of two voluntary temporary abstinence periods
了解酒精使用障碍的恢复:两个自愿临时戒酒期的纵向观察
  • 批准号:
    10740677
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Sleep Disturbances During Cocaine Abstinence, Dopamine Adaptations, and Motivation for Cocaine
可卡因戒断期间的睡眠障碍、多巴胺适应和可卡因动机
  • 批准号:
    10681668
  • 财政年份:
    2023
  • 资助金额:
    $ 84.85万
  • 项目类别:
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
  • 批准号:
    10540014
  • 财政年份:
    2022
  • 资助金额:
    $ 84.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了